i) Breezula is estimated for 2023 ;
ii) There are solid reasons to believe Breezula will not be as efficient as finasteride but rather side-effect "free" (or less) ;
iii) Parrati only sells liposomal finasteride with prescription ;
iv) Parrati is Italian, so they do ship to EU ;
v) Polichem should be on the market (if approved by FDA/EMA) by end of Q3/Q4 2020.
I honestly don't know what pushed Almirall and Polichem to release this drug. As far as we know, at high concentration (0,25% equivalent to 1 mg), topical finasteride has the same impact on serum DHT as oral finasteride. Nobody knows yet at what final concentration Polichem will put its drug on the market.
We have talked about it for a long time now but the only good thing is the study they performed with low dose topical finasteride (attached). The main finding is that concentration of 0.025% induces a drop of c. 50% of scalp DHT while serum DHT only dropped by 25%. It is, however, shown that at high concentration (around 0.25%), topical finasteride has the same impact on serum DHT as oral finasteride. The thing is, we are not even sure scalp DHT is what is causing hair loss...
This being said, I am actually discussing with my tricho the possibility of a 0.025% finasteride topical solution.